A Phase I, Double-Blind, Single Ascending Dose Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Activity of TRL1068 in Subjects with Prosthetic Joint Infection of the Knee or Hip and Undergoing Primary Two-Stage Exchange Arthroplasty.